Form 4: NeuroOne Medical Technologies: Officer Mertens Disposes of Shares to Cover Tax Obligations
SEC Form 4 Filing
Chief Technology Officer Steve Mertens disposed of 252 shares of NeuroOne Medical Technologies to cover tax obligations arising from a previous transaction.
Summary
- On May 31, 2024, Steve Mertens, Chief Technology Officer of NeuroOne Medical Technologies Corp, disposed of 252 shares of common stock.
- The transaction was executed to cover tax obligations.
- The price per share was $0.9299.
- Following the transaction, Mertens directly owns 176,157 shares of NeuroOne Medical Technologies Corp.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing detailing a routine transaction. It doesn't inherently convey positive or negative sentiment.
Industry Context
This Form 4 filing is a routine disclosure related to insider transactions and provides transparency to the market regarding the trading activities of company officers.
Stakeholder Impact
- The transaction has a minimal impact on stakeholders as it is a small disposal of shares by an officer to cover tax obligations.
Key Dates
| Date | Description |
|---|---|
| 05/31/2024 | Date of transaction: Steve Mertens disposed of shares. |
| 06/04/2024 | Date of signature: Stephanie Swan signed the document on behalf of Steve Mertens. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.